Alberto Doretti

Neurology — Istituto Auxologico Italiano, Italy

LeadR Profile

Alberto Doretti Istituto Auxologico Italiano Italy
429 ScienceLeadR Reputation 429
Network Map

Neurology

Subspecialties: Public Health - Psychology - Psychiatry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2026 - 2026

Source: PubMed

Istituto Auxologico Italiano Istituto di Ricovero e Cura a Carattere Scientifico

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 95

Citations

Citations: 1 181 1st author: 1 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
White matter hyperintensity burden in amyotrophic lateral sclerosis: motor and survival correlates.
white matter, sclerosis, neurons, motor neurons, cognitive dysfunction, amyotrophic lateral sclerosis, cognition disorders, neurology, prognosis
Brain20260
Migraine with visual aura, unilateral mydriasis and Takotsubo Syndrome. Random coincidence or common pathogenesis? The precarious balance of the autonomic nervous system and the complex relationship between brain and heart: a review of the literature.
autonomic nervous system, hypothalamus, heart, stress, physiological, brain, migraine disorders, nervous system, takotsubo cardiomyopathy, mydriasis
Front Neurol20260
Neuropsychological Sub-Phenotypes in Amyotrophic Lateral Sclerosis.
neuropsychology, sclerosis, phenotype, cognitive dysfunction, amyotrophic lateral sclerosis, nervous system diseases
Eur J Neurol20260
Correction: Real‑World Response and Super‑Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study.
migraine disorders
Neurol Ther20260
Responders and super-responders to atogepant after 24 weeks of treatment in migraine: real-world evidence from the GIANT-2 study.
headache, comorbidity, pain, migraine disorders, therapeutics
J Headache Pain20261

Clinical Studies 20

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 14
Phase 3 5
Phase 2/Phase 3 1

By status:

Recruiting 11
Completed 3
Unknown 3
Active not recruiting 2
Not yet recruiting 1

By type:

Observational 12
Interventional 8

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 7
multicentric5to9 1
multicentricup10 6

Main Topics

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A clinical trial to evaluate efficacy and safety of Xeomin injections for preventing chronic migraine
2024-515682-34-00 — injections, safety, migraine disorders
Phase 3Recruiting2025
A clinical trial to evaluate efficacy and safety of Xeomin injections for preventing episodic migraine
2024-515715-22-00 — injections, safety, migraine disorders
Phase 3Recruiting2025
Evaluation of the Performance of the Doraldo Castelletti Scale in Supporting the Neurologist s Decision to Refer Migraine Patients to Physiotherapy
NCT07626307 — headache, migraine disorders, motivation, physicians, neurologic examination, therapeutics, neurologists, neurology, neck
N/ARecruiting2025
i NEED NEw migrainE Drugs Database
NCT07103694 — headache, genes, naproxen, calcitonin gene-related peptide receptor antagonists, calcitonin gene-related peptide, safety, antibodies, pharmaceutical preparations, migraine disorders, receptors, calcitonin gene-related peptide, antibodies, monoclonal, therapeutics, headache disorders, receptors, peptide, prescription drug overuse, headache disorders, secondary, calcitonin, sumatriptan
N/ARecruiting2022
OnaBotulinumtoxin A in Chronic Migraine Patients with Short or Long Disease History (the BACH Study)
NCT06537700 — headache, comorbidity, migraine disorders, botulinum toxins, type a, botulinum toxins, therapeutics, history
N/ARecruiting2024

LeadR Networks

Main global connection map